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To investigate the prevalence of, and the risk factors for, cervical infection with 44 types of human papillomavirus (HPV) in a rural area
in the Dindigul District, Tamil Nadu, India, we interviewed and obtained cervical cell samples from 1891 married women aged 16–59
years. HPV prevalence was 16.9% overall and 14.0% among women without cervical abnormalities, or 17.7 and 15.2%, respectively,
age-standardised to the world standard population. In all, 21.9% of infections involved more than one HPV type. High-risk HPV types
predominated, particularly HPV 16 (22.5% of women infected), followed by HPV 56, HPV 31, HPV 33 and HPV 18. Unlike most
populations studied in developed countries, HPV prevalence was constant across the age groups. HPV positivity was inversely
associated with education level (odds ratio (OR) among women with high school vs no education¼0.6) and positively associated
with widowhood and divorce (OR¼1.7), nulligravidity (OR¼2.3), and condom use (OR¼2.6). It is unclear how much low
clearance of, or frequent reinfection with HPV accounted for the study prevalence of infection in different age groups.
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The prevalence of human papillomavirus (HPV) is low in some
populations in Asia (Anh et al, 2003) and Europe (de Sanjose ´ et al,
2003), although it exceeds 15% in women aged 15–74 years in
some parts of Latin America (Molano et al, 2002) and sub-Saharan
Africa (Thomas et al, 2004), where incidence rates for cervical
cancer are very high (Ferlay et al, 2001). HPV prevalence shows
different patterns of infection by age in different populations.
Much higher HPV prevalences were generally found below age 25
(Molano et al, 2002; Shin et al, 2003; Peto et al, 2004) or 35 years
(Ronco et al, 2005) than above these ages, but in a very high HPV-
prevalence area (Ibadan, Nigeria), the proportion of HPV-positive
women was similar in all 10-year age groups between 15 and 65
years or more (Thomas et al, 2004).
Information on HPV prevalence and type-specific distribution
among Indian women is scanty (Duttagupta et al, 2004). We have,
therefore, carried out an HPV survey in a rural area in southern
India.
MATERIALS AND METHODS
We carried out the present study between February and October
2003 in the Dindigul District, Tamil Nadu, India as a collaborative
project between the Christian Fellowship Community Health
Centre (CFCHC) and the International Agency for Research on
Cancer (IARC). The study area is rural, at an average elevation of
600m above sea level in the foothills of the Western Ghats and
consists of 324 village panchayats (local administrative structures
consisting of 4–23 villages). The study goal was to assess the
prevalence of cervical HPV infection and cytological abnormalities
in a sample of 2000 married, nonpregnant women aged 16–59
years, but we searched for an approximately two-fold larger
population to compensate for ineligibility and refusals. We
therefore randomly selected a few villages in the study district,
as follows.
After excluding the 113 village panchayats that participated in a
concurrent IARC randomised trial of cervical visual screening
(Sankaranarayanan et al, 2004), we stratified the remaining village
panchayats according to their total population (small: o3000;
intermediate: 3000–5000; large: X5000 people). We then ran-
domly extracted nine small size, three intermediate size, and
one-third of a large size village panchayat in order to obtain
an approximately equal number of women from each stratum.
The study working team, consisting of one medical doctor
(R Rajkumar), three ad hoc trained nurses, and three healthcare
workers, stayed in each selected village for 2–5 days and visited
each household to invite eligible women. Women who agreed to
participate signed informed consent forms as recommended by the
ethics committees of the CFCHC and IARC, both of which
approved this study. A structured questionnaire including
information on sociodemographic characteristics, reproductive
factors and use of contraceptive methods was administered in the
local language (Tamil) in women’s homes and an appointment was
arranged in the temporary clinic that had been installed in each
village during the survey.
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Women underwent a pelvic examination, performed by one of the
three nurses. None had undergone a hysterectomy. Samples of
exfoliated cells from the ecto- and endocervix were collected with a
broom-type brush and placed in vials of PreservCyt solution,
according to the manufacturer’s instructions (Cytyc, Boxborough,
MA, USA). All samples were stored at þ41C until shipment to the
Department of Pathology at the Vrije University Medical Center,
Amsterdam, The Netherlands, for HPV testing and liquid-based
cytology. In order to meet the immediate screening needs of
participating women, visual inspection with acetic acid and, in the
presence of suspicious lesions, colposcopy, were performed
(Sankaranarayanan et al, 2004). Acetowhite lesions were treated,
mainly with cryotherapy. Women with cervicovaginitis received
antibiotic treatment. When cytology results became available,
women with high-grade squamous intraepithelial lesions (HSIL)
were recalled, biopsied and treated with cryotherapy or loop
electrosurgical excision as appropriate.
Cytology
Liquid-based ThinPrep cytology slides were prepared from
PreservCyt vial specimens according to the manufacturer’s
standard protocol. Results were classified by cytotechnicians
according to the CISOE-A classification (Bulk et al, 2004), and
abnormal smears were reviewed by an experienced cytopatholo-
gist. Cytological evidence of infection with Trichomonas (T.)
vaginalis was reported systematically.
Human papillomavirus detection techniques
To analyse the quality of the target DNA for polymerase chain
reaction (PCR) testing, cervical specimens were screened with beta
(b)-globin gene-specific primers. HPV positivity was assessed by
general primer-mediated GP5þ/GP6þ-PCR and by hybridisation
of PCR products in an enzyme immunoassay (EIA) using two HPV
oligoprobe cocktails that, together, detect the following 44 HPV
types: HPV 6, 11, 16, 18, 26, 30, 31, 32, 33, 34, 35, 39, 40, 42, 43, 44,
45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 64, 66, 67, 68, 69, 70, 71
(equivalent to CP8061), 72, 73, 81 (equivalent to CP8304), 82
(IS39 and MM4 subtypes), 83 (equivalent to MM7), 84 (equivalent
to MM8), cand85, 86, cand89 (equivalent to CP6108) and
JC9710. PCR products that were positive in the EIA were
subsequently subjected to further typing by reverse line blot
hybridisation, as described previously (van den Brule et al,
2002).
High-risk HPV types for this analysis included HPV 16, 18, 26,
31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 (Mun ˜oz
et al, 2003). The group of low-risk types included all other HPV
types.
Statistical analysis
Odds ratios (ORs) for HPV positivity with 95% confidence
intervals (CIs) by various women’s characteristics were calculated
using unconditional, multiple logistic regression adjusted for age
group (o25, 25–34, 35–44, 45–54, X55 years). The statistical
significance of trends for ORs was assessed by giving increasing
scores to successive categories of appropriate variables in the
logistic model.
RESULTS
Of the 2884 women invited, 154 could not be enrolled in the study
because they were pregnant, 31 because of illness and 13 because of
heavy menstrual bleeding, thus leaving 2686 eligible candidates.
There were 743 refusals (27.7%) mainly because of lack of time
(372) and reluctance to undergo a gynaecological examination
(331). Women who refused to participate were similar to the
participating ones in relation to their occupation, husband’s
occupation, religion, marital status, age at marriage, number of
pregnancies and use of contraceptive methods. The only
characteristics that were associated with refusals were age (highest
below age 25 and above age 54) and education (with the minority
of women with high school or college having a participation 10%
lower than less educated women).
Of the 1943 women who underwent a pelvic examination, 62
women had acetowhite lesions on visual inspection, 49 had
inadequate cytology results and three had b-globin-negative HPV
samples. Of the 1891 women with valid cytology and HPV results,
92 (4.9%) had abnormal cytological findings, including 46 with
borderline dyskaryosis, 26 with mild dyskaryosis, 13 with
moderate dyskaryosis and seven with severe dyskaryosis. Whereas
the frequency of borderline dyskaryosis was similar in different
age groups, moderate or severe dyskaryosis was never found
in women under age 25, and steadily increased from age
25–34 (1.0%) to age 45–59 (2.3%, Figure 1). None of the
study women reported previous cytological screening for cervical
cancer.
The prevalence of HPV of any type was 16.9%, but it varied
between 14.0% among cytologically normal women and 73.9%
among those with cytological abnormalities (Table 1). The
corresponding proportions age-standardised to the world popula-
tion were 17.7% overall, 15.2% among those without and 64.9%
among those with cytological abnormalities. In total, 250 women
had single-type and 70 had multiple-type infection.
High-risk HPV types were substantially more frequent (12.5% of
all women) than low-risk types (6.0%). Most commonly found in
either single- or multiple-type infections were HPV 16 (3.8%),
HPV 42 (a low-risk type, 2.2%), HPV 56 (1.5%), HPV 31 (1.2%),
HPV 33 (1.2%) and HPV 18 (1.0%), but HPV type distribution
varied by cytological results. High-risk types were found in 70.7%
of women with cytological abnormalities and in 17 out of 20
(85.0%) women with moderate or severe dyskaryosis (including
HPV 16 or 18 in nine women). Details of HPV types found in
women with multiple HPV infections are given in Appendix A
(Table A1). The prevalence of HPV (any type, high- and low-risk
types, separately) was similar in women in different age groups
(Figure 2, Table 2).
Tables 2 and 3 show the relationship between HPV positivity
and major characteristics of study women after adjustment for age.
Education level was inversely associated with HPV prevalence (OR
for women with high school or college degrees vs illiterate
women¼0.6; 95% CI: 0.4–1.0), whereas women working outside
the house (the vast majority as farm labourers) had an excess of
HPV positivity of borderline statistical significance (OR vs
housewives¼1.3; 95% CI: 1.0–1.6, Table 2). Husband’s occupation
0
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Figure 1 Prevalence of dyskaryosis at liquid-based cytology by degree of
dyskaryosis and by age group. (Dindigul, India).
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were not associated with HPV positivity (Table 2).
Women who were widowed (OR¼1.7; 95% CI: 1.0–2.7), and
separated or divorced (OR¼2.3; 95% CI: 0.8–6.7) showed a higher
proportion of HPV positivity than married women (Table 3). The
median age at marriage was 18 years (range¼12–33) and the
median number of pregnancies was three (range¼0–14). The
median age at first pregnancy was 19 years (range¼13–34). Child
deliveries after age 30 were reported by only 5.9% of women. Age
at first marriage and number of pregnancies among ever-pregnant
women were unrelated to HPV positivity, although an OR of 2.3
(95% CI: 1.3–4.2) was found among the few nulligravidae (3% of
all study women). Spontaneous or voluntary abortions were
reported by 21.6% of HPV-negative and 25.9% of HPV-positive
women (data not shown). Among contraceptive methods, only
tubal ligation was reported often (63% of study women) and was
unrelated to HPV positivity. An increased risk of HPV positivity
was found, however, among 30 women who reported condom use
(OR¼2.6; 95% CI: 1.2–5.7). Finally, cytological evidence of
infection with T. vaginalis was found in 6.0% of study women
and was associated with an OR for HPV positivity of 1.5 (95% CI:
0.9–2.3, Table 3).
When education level, marital status, number of pregnancies,
and contraceptive methods were included, in addition to age, in
the same multiple logistic regression, the corresponding ORs did
not change materially.
Table 1 Prevalence of various human papillomavirus (HPV) types by cytological findings and overall among 1891 women (Dindigul, India)
Cytology
Normal Abnormal Total
HPV type
a Single Multiple Total (%) Single Multiple Total (%) Single Multiple Total (%)
Negative 1547 (85.9) 24
b (26.1) 1571 (83.1)
Positive, any 199 53 252 (14.0) 51 17 68 (73.9) 250 70 320 (16.9)
High risk 125 47 172 (9.6) 49 16 65 (70.7) 174 63 237 (12.5)
Low risk 68 34 102 (5.7) 2 9 11 (12.0) 70 43 113 (6.0)
Uncharacterised 6 – – 6 (0.3) – – – – 0 6 – – 6 (0.3)
High risk
16 30 21 51 (2.8) 15
c 6
d 21 (22.8) 45 27 72 (3.8)
18 8 7 15 (0.8) 3
e 1 4 (4.3) 11 8 19 (1.0)
26 1 0 1 (0.1) 0 0 0 1 0 1 (0.1)
31 11 3 14 (0.8) 7
d 2
e 9 (9.8) 18 5 23 (1.2)
33 8 6 14 (0.8) 4 4
d 8 (8.7) 12 10 22 (1.2)
35 7 7 14 (0.8) 1 3
d 4 (4.4) 8 10 18 (1.0)
39 4 6 10 (0.6) 0 1
d 1 (1.1) 4 7 11 (0.6)
45 3 3 6 (0.3) 2
d 1 3 (3.3) 5 4 9 (0.5)
51 5 3 8 (0.4) 5
e 1 6 (6.5) 10 4 14 (0.7)
52 11 2 13 (0.7) 1 0 1 (1.1) 12 2 14 (0.7)
53 1 2 3 (0.2) 0 1 1 (1.1) 1 3 4 (0.2)
56 14 5 19 (1.1) 7
d 3 10 (10.9) 21 8 29 (1.5)
58 1 2 3 (0.2) 3 1
d 4 (4.4) 4 3 7 (0.4)
59 11 1 12 (0.7) 1 0 1 (1.1) 12 1 13 (0.7)
66 6 3 9 (0.5) 0 0 0 6 3 9 (0.5)
73 2 1 3 (0.2) 0 0 0 2 1 3 (0.2)
82 2 2 4 (0.2) 0 0 0 2 2 4 (0.2)
Low risk
6 2 2 4 (0.2) 0 1 1 (1.1) 2 3 5 (0.3)
30 3 0 3 (0.2) 0 1 1 (1.1) 3 1 4 (0.2)
32 1 2 3 (0.2) 0 0 0 1 2 3 (0.2)
40 2 4 6 (0.3) 0 0 0 2 4 6 (0.3)
42 25 12 37 (2.1) 1 3 4 (4.4) 26 15 41 (2.2)
43 0 3 3 (0.2) 0 2 2 (2.2) 0 5 5 (0.3)
44 0 1 1 (0.1) 0 0 0 0 1 1 (0.1)
54 3 2 5 (0.3) 0 0 0 3 2 5 (0.3)
55 1 1 2 (0.1) 0 0 0 1 1 2 (0.1)
67 1 2 3 (0.2) 0 2 2 (2.2) 1 4 5 (0.3)
69 1 0 1 (0.1) 0 0 0 1 0 1 (0.1)
70 3 3 6 (0.3) 0 0 0 3 3 6 (0.3)
81 5 3 8 (0.4) 0 2 2 (2.2) 5 5 10 (0.5)
83 1 0 1 (0.1) 0 0 0 1 0 1 (0.1)
84 1 1 2 (0.1) 0 0 0 1 1 2 (0.1)
85 5 0 5 (0.3) 0 0 0 5 0 5 (0.3)
86 2 0 2 (0.1) 0 0 0 2 0 2 (0.1)
CP6108 3 0 3 (0.2) 0 0 0 3 0 3 (0.2)
JC9710 9 9 18 (1.0) 1 0 1 (1.1) 10 9 19 (1.0)
aThe same woman can appear more than once in ‘Multiple’ and ‘Total’ columns.
bIncludes three high-grade squamous intraepithelial lesions.
cIncludes six high-grade squamous
intraepithelial lesions.
dIncludes one high-grade squamous intraepithelial lesion.
eIncludes two high-grade squamous intraepithelial lesions.
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The main findings of our large survey in Dindigul District in rural
India are the high overall prevalence of HPV infection, the similar
prevalence across different age groups, and the marked predomi-
nance of HPV 16 among HPV types.
All-age HPV prevalence in Dindigul District is similar to that
found in high-risk areas for cervical cancer in Latin America
(Molano et al, 2002; Matos et al, 2003), although lower than in
some parts of sub-Saharan Africa (Thomas et al, 2004). No clear
peak in HPV prevalence was found in young women in Dindigul
District, whereas in most countries studied so far the prevalence of
HPV below age 25 is X2-fold higher than at 45 or above (Molano
et al, 2002; Peto et al, 2004). However, a constant prevalence of
HPV across age groups has been recently reported in Nigeria
(Thomas et al, 2004), suggesting that in some poor countries the
risk of HPV infection is similar in different generations of women
in contrast to the markedly higher HPV prevalence among younger
women in many developed countries (Peto et al, 2004). Low rates
of HPV clearance and frequent HPV reinfections may also
contribute to the steady age pattern observed in Dindigul District
and Nigeria (Thomas et al, 2004).
India shows some of the highest rates of cervical cancer
worldwide (Ferlay et al, 2001), particularly in rural areas
(Rajkumar et al, 2000). The combined prevalence in a rural area
of West Bengal of HPV types 16 and 18 in 534 Hindu women and
478 Muslim women was 7.5 and 9.6%, respectively (Duttagupta
et al, 2004). HPV 16 and 18 positivity was similar in four age
groups (o25, 25–34, 35–44, X45 years) among Muslim women,
but steeply declined with age among Hindu women.
Our survey is the first study to assess a broad range of HPV
types in different age groups in India in a large sample of women.
It showed that HPV 16 is the most frequently found type in the
general population, affecting 22.5% of HPV-positive women. The
corresponding percentages in IARC surveys in Asia and Africa
were less than 14% (Shin et al, 2003; Thomas et al, 2004). The
predominance of HPV 16 in the Indian population is similar to
that found with the same PCR-assay in Europe (32.6%, Ronco et al,
2005) and Latin America (22.0%, Molano et al, 2002). Of note, a
high proportion (63.2%) of cervical cancer specimens was also
found to be positive for HPV 16 in India (Franceschi et al, 2003).
Among other HPV types, a relatively high frequency of HPV 42
and HPV 56 (the second most frequent high-risk type in Dindigul)
was found in previous IARC surveys (Anh et al, 2003; Thomas et al,
2004). HPV 42 is a low-risk type while HPV 56 seems to be one of
the high-risk types like HPV 31, 33, 35, 52, 53 and 58 that is
substantially under-represented in invasive cancer compared to
preinvasive cervical lesions (Clifford et al, 2003).
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Figure 2 Age-specific prevalence of cervical human papillomavirus
(HPV) DNA. (Dindigul, India).
Table 2 Detection of cervical human papillomavirus (HPV) DNA according to sociodemographic characteristics among 1891 women
a (Dindigul, India)
HPV DNA positive
Number of women Number (%) OR
b (95% CI)
Age (years)
o25
c 334 56 (16.8) 1
25–34 847 137 (16.2) 0.96 (0.68–1.35)
35–44 446 82 (18.4) 1.12 (0.77–1.63)
45–54 228 39 (17.1) 1.02 (0.65–1.60)
X55 36 6 (16.7) 0.99 (0.39–2.50)
w
2
1 for trend 0.23 P¼0.63
Education
Illiterate
c 869 158 (18.2) 1
Primary or secondary 754 128 (17.0) 0.91 (0.70–1.19)
High school or college 261 32 (12.3) 0.63 (0.41–0.95)
w
2
1 for trend 4.00 P¼0.05
Occupation
Manual worker/farmer 1022 189 (18.5) 1.28 (0.99–1.64)
Housewife
c 812 122 (15.0) 1
Others 53 8 (15.1) 0.99 (0.46–2.18)
Husband’s occupation
Manual worker
c 1132 192 (17.0) 1
Farmer 431 68 (15.8) 0.91 (0.67–1.23)
Others 172 24 (14.0) 0.79 (0.50–1.25)
Religion
Hindu
c 1643 284 (17.3) 1
Christian 240 36 (15.0) 0.83 (0.57–1.21)
Muslim 6 0 (0.0) 0.00 (0.00–N)
aFigures do not add up to the total because of missing values.
bAdjusted for age.
cReference category; OR¼Odds ratio; CI¼Confidence interval.
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high-quality liquid-based cytology in a population that had never
been screened before. Most previous surveys in developing
countries (Duttagupta et al, 2004), including those by IARC, had
to rely on locally read cytology and indeed showed a much lower
agreement between cytological findings and HPV results than in
our present study, where 85% of moderate and severe dyskaryosis
(corresponding to high-grade squamous intraepithelial lesions,
HSIL) harboured high-risk HPV types. Moderate or severe
dyskaryoses were never found below 25 years in Dindigul
District, but their prevalence increased with age and in women
aged 45 or older it was approximately four-fold greater than in
women in the same age group in England (Department of Health,
2000).
Only a few of the possible correlates of HPV positivity could be
evaluated, since inclusion of unmarried women and questions
about sexual habits were discouraged during our preparatory
meetings with the village heads and local collaborators in Dindigul.
The study took place, however, in a rather homogenous, low-
income rural population and it is, therefore, not surprising that the
very few characteristics that stood out as being directly (e.g.,
nulligravidity, widowhood or divorce, and condom use) or
indirectly (high school or college degree) associated with HPV
positivity involved a small, and sometimes very small, proportion
of study women.
The uniformity of living standards and lifestyle in rural India
provides some reassurance in respect of selection bias. Two main
groups of women accounted for nonparticipation in our study:
those who were not traced during the few days that the
gynaecological clinic stayed in each village (approximately 25%
of women), and those who were contacted but refused to
participate (an additional 19%) mainly out of a lack of familiarity
with gynaecological examinations. However, we were able to
obtain some basic information from almost all women during the
survey, or in subsequent repeated visits to the same villages. The
three main groups (participants, refusals, and untraced women)
were similarly distributed by sociodemographic and reproductive
factors.
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Table 3 Detection of cervical human papillomavirus (HPV) DNA according to marital status, reproductive factors, contraceptive use and Trichomonas
vaginalis infection among 1891 women
a (Dindigul, India)
HPV DNA positive
Number of women Number (%) OR
b (95% CI)
Age at marriage (years)
p15
c 351 59 (16.8) 1
16–17 528 96 (18.2) 1.10 (0.77–1.57)
18–19 566 91 (16.1) 0.95 (0.66–1.36)
X20 438 69 (15.8) 0.92 (0.63–1.35)
w
2
1 for trend 0.57 P¼0.45
Marital status
Married
c 1767 288 (16.3) 1
Widowed 107 26 (24.3) 1.66 (1.03–2.67)
Separated or divorced 16 5 (31.3) 2.30 (0.79–6.71)
Age at menarche (years)
p12
c 332 58 (17.5) 1
13–14 887 156 (17.6) 1.01 (0.72–1.41)
X15 628 91 (14.5) 0.79 (0.55–1.14)
w
2
1 for trend 2.15 P¼0.14
Number of pregnancies
0 59 17 (28.8) 2.31 (1.26–4.22)
1–2
c 848 128 (15.1) 1
3–4 749 137 (18.3) 1.22 (0.92–1.62)
X5 235 38 (16.2) 1.03 (0.66–1.60)
w
2
1 for trend 0.09 P¼0.76
Contraceptive method
None
c 657 118 (18.0) 1
Tubal ligation 1183 189 (16.0) 0.85 (0.65–1.11)
Condom 30 11 (36.7) 2.63 (1.22–5.68)
Others
d 13 1 (7.7) 0.38 (0.05–2.95)
Trichomonas vaginalis infection
Negative
c 1777 294 (16.5) 1
Positive 114 26 (22.8) 1.48 (0.94–2.34)
aFigures do not add up to the total because of missing values.
bAdjusted for age.
cReference category.
dIncluding seven users of oral contraceptives and six users of intrauterine
device; OR¼Odds ratio; CI¼confidence interval.
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Appendix A
Table A1 shows the details of HPV types found in women with
multiple HPV infections.
Table A1 Combinations of human papillomavirus (HPV) types in 70
women with multiple infections (Dindigul, India)
HPV type No. HPV type No. HPV type No.
6,16 1 16,JC9710 1 35,66 1
6,18 1
a 18,35 1 35,70 1
6,56 1 18,40 1 35,81 1
a
16,18 2 18,53,42 1 39,56 1
16,18,39 2 30,81 1
a 40,43 1
16,33 2
a 31,33 1
a 40,54,59 1
16,33,39 1 31,39 1
a 42,43 1
16,35,40 1 31,42 1 42,51 2
a
16,39 2 31,51 1 42,52 1
16,42 2 31,82 1 42,53 1
16,42,43 1
a 32,JC9710 2 42,81,JC9710 1
16,51,55,66,JC9710 1 33,45 2 42,82 1
16,53 1
a 33,52 1 43,45 2
a
16,56 3
a 33,56 2
b 54,58 1
16,67 3
b 33,JC9710 1 58,84,JC9710 1
16,67,81 1 35,42 2
a 66,JC9710 1
16,70 1 35,42,56 1 70,JC9710 1
16,73 1 35,44 1
16,81 1 35,58 1
a
High-risk types in bold face.
aOne woman with abnormal cervical findings.
bTwo
women with abnormal cervical findings.
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